NFA
PDSB icon

Nationwide Fund Advisors’s PDS Biotechnology PDSB Stock Holding History

Nationwide Fund Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-463
Closed -$99K – 1511
2017
Q3 		$99K Hold
463
– – ﹤0.01% 2903
2017
Q2 		$95K Hold
463
– – ﹤0.01% 2924
2017
Q1 		$84K Sell
463
-49
-10% -$9.71K ﹤0.01% 2888
2016
Q4 		$128K Hold
512
– – ﹤0.01% 2790
2016
Q3 		$107K Hold
512
– – ﹤0.01% 2866
2016
Q2 		$104K Buy
512
+214
+72% +$37.8K ﹤0.01% 2899
2016
Q1 		$55K Buy
298
+47
+19% +$8.4K ﹤0.01% 2970
2015
Q4 		$63K Buy
+251
New +$80.9K ﹤0.01% 2959

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nationwide Fund Advisors's PDSB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of PDS Biotechnology (PDSB) in Q4 2017, closing a stake of 463 shares — an estimated $99K sold.

Nationwide Fund Advisors first reported a position in PDSB in Q4 2015 and held it in 8 quarters. The position peaked at $128K in Q4 2016. 57 funds tracked by Wall St. Rank hold PDSB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining PDS Biotechnology position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 463 PDS Biotechnology shares in Q4 2017, an estimated $99K.
  • Nationwide Fund Advisors first reported a position in PDS Biotechnology in Q4 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's PDS Biotechnology position peaked at $128K in Q4 2016.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.